Atai Life Sciences N.V.

NASDAQ:ATAI

1.28 (USD) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -40.224-157.417-174.244-178.625-24.384
Depreciation & Amortization 0.3190.1680.0470.0240.006
Deferred Income Tax 05.07439.13556.3467.536
Stock Based Compensation 32.98242.37563.36267.1580.057
Change In Working Capital 7.469-3.335-7.6044.45-0.126
Accounts Receivables 00000
Inventory 00000
Accounts Payables 2.138-3.0342.31.7040.249
Other Working Capital 5.331-0.301-9.9042.746-0.375
Other Non Cash Items -84.6648.66816.05829.8819.065
Operating Cash Flow -84.118-104.467-63.246-20.766-7.846
Investing Activities:
Investments In Property Plant And Equipment -0.59-1.024-1.128-0.059-0.019
Acquisitions Net -0.4430-52.937-2.088-0.456
Purchases Of Investments -185.262-309.658-23.658-23.92-11.55
Sales Maturities Of Investments 139.469226.834-0.955010.313
Other Investing Activites -6.469-3-2.598-2.204-7.319
Investing Cash Flow -53.295-86.848-81.276-28.271-9.031
Financing Activities:
Debt Repayment 0151.58832.5030
Common Stock Issued 0.2254.636409.88482.43942.684
Common Stock Repurchased 00000
Dividends Paid 00000
Other Financing Activities -8.3555.785-1.61-1.89-2.295
Financing Cash Flow -8.35520.785409.862113.05240.389
Other Information:
Effect Of Forex Changes On Cash 0.189-1.123-0.323.169-0.372
Net Change In Cash -145.579-171.653265.0267.18423.14
Cash At End Of Period 45.034190.613362.26697.24630.062